BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM
459 results:

  • 1. Clinical and genetic analysis of a case of Gitelman syndrome accompanied with Graves disease and adrenocortical adenoma: A case report.
    Qiao Y; Zhao J; Wu J; Cao L; Song G; Mao J
    Medicine (Baltimore); 2024 Apr; 103(15):e37770. PubMed ID: 38608089
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer.
    Mehra T; Lupatsch JE; Kössler T; Dedes K; Siebenhüner AR; von Moos R; Wicki A; Schwenkglenks ME
    PLoS One; 2024; 19(4):e0301271. PubMed ID: 38573891
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The association between serum selenium levels and pathological features of papillary thyroid cancer in 284 patients.
    Ge S; Zhao J; Yao J; Fu H; Tian Y; Shan Y; Sun M; Feng J; Dong J; Liao L
    Front Endocrinol (Lausanne); 2023; 14():1242250. PubMed ID: 38027150
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The association between thyroid and breast cancers: a bidirectional mendelian randomization study.
    Liu J; Liang L
    Front Endocrinol (Lausanne); 2023; 14():1185497. PubMed ID: 37955011
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Socioeconomic differences between medically and surgically treated prolactinomas: a retrospective review of 598 patients.
    Osorio RC; Haddad AF; Hart DM; Goldrich N; Badani A; Kabir AS; Juncker R; Oh JY; Carrete L; Peeran Z; Chalif EJ; Zheng AC; Braunstein S; Theodosopoulos PV; El-Sayed IH; Gurrola J; Kunwar S; Blevins LS; Aghi MK
    J Neurosurg; 2024 Mar; 140(3):712-723. PubMed ID: 37877974
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network.
    Jannin A; Giudici F; de la Fouchardière C; Al Ghuzlan A; Wassermann J; Chougnet CN; Drui D; Godbert Y; Ilouz F; Bardet S; Zanetta S; Roudaut N; Batisse Lignier M; Groussin L; Klein M; Zerdoud S; Lamartina L; Baudin E; Decaussin-Petrucci M; Leteurtre E; Borson Chazot F; Do Cao C; Borget I; Hadoux J;
    Thyroid; 2023 Oct; 33(10):1190-1200. PubMed ID: 37855745
    [No Abstract]    [Full Text] [Related]  

  • 7. Analysis of the cost-effectiveness of proton beam therapy for unresectable pancreatic cancer in Japan.
    Hiroshima Y; Kondo M; Sawada T; Hoshi SL; Okubo R; Iizumi T; Numajiri H; Okumura T; Sakurai H
    Cancer Med; 2023 Oct; 12(20):20450-20458. PubMed ID: 37795771
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cigarette smoking and thyroid cancer risk: A Mendelian randomization study.
    Jiang H; Li Y; Shen J; Lin H; Fan S; Qiu R; He J; Lin E; Chen L
    Cancer Med; 2023 Oct; 12(19):19866-19873. PubMed ID: 37746910
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical value of grayscale ultrasound combined with real-time shear wave elastography nomogram in risk prediction of thyroid cancer.
    Ren T; Jiang M; Wu J; Zhang F; Zhang C
    BMC Med Imaging; 2023 Sep; 23(1):123. PubMed ID: 37700270
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A putative role for ALDH inhibitors and chemoprevention of BRCA-mutation-driven tumors.
    McGonigal S; Wu R; Grimley E; Turk EG; Zhai Y; Cho KR; Buckanovich RJ
    Gynecol Oncol; 2023 Sep; 176():139-146. PubMed ID: 37535994
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Facilitation of Definitive cancer Diagnosis With Quantitative Molecular Assays of BRAF V600E and TERT Promoter Variants in Patients With Thyroid Nodules.
    Fu G; Chazen RS; Monteiro E; Vescan A; Freeman JL; Witterick IJ; MacMillan C
    JAMA Netw Open; 2023 Jul; 6(7):e2323500. PubMed ID: 37505499
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Searching for prognostic markers for Stage I epithelial ovarian cancer: A role for systemic inflammatory markers.
    Borella F; Bertero L; Valabrega G; Fucina S; Cassoni P; Benedetto C
    Int J Gynaecol Obstet; 2024 Jan; 164(1):262-269. PubMed ID: 37496460
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. TERT Promoter Mutations Frequency Across Race, Sex, and cancer Type.
    El Zarif T; Machaalani M; Nawfal R; Nassar AH; Xie W; Choueiri TK; Pomerantz M
    Oncologist; 2024 Jan; 29(1):8-14. PubMed ID: 37462445
    [TBL] [Abstract] [Full Text] [Related]  

  • 14.
    Fukuda K; Seki N; Yasudome R; Mitsueda R; Asai S; Kato M; Idichi T; Kurahara H; Ohtsuka T
    Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239355
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Radiotherapy in recurrent ovarian cancer: updated results of involved-field radiation therapy.
    Lee BM; Lee SJ; Kim N; Byun HK; Kim YB
    Int J Gynecol Cancer; 2023 Jul; 33(7):1106-1111. PubMed ID: 37217239
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Integration of Artificial Intelligence Decision Aids to Reduce Workload and Enhance Efficiency in Thyroid Nodule Management.
    Tong WJ; Wu SH; Cheng MQ; Huang H; Liang JY; Li CQ; Guo HL; He DN; Liu YH; Xiao H; Hu HT; Ruan SM; Li MD; Lu MD; Wang W
    JAMA Netw Open; 2023 May; 6(5):e2313674. PubMed ID: 37191957
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Validation of the KELIM score as a predictor of response to neoadjuvant treatment in patients with advanced high grade serous ovarian cancer.
    Piedimonte S; Kim R; Bernardini MQ; Atenafu EG; Clark M; Lheureux S; May T
    Gynecol Oncol; 2022 Dec; 167(3):417-422. PubMed ID: 37191644
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comparing surgical outcomes of approaches to adrenalectomy - a systematic review and network meta-analysis of randomised clinical trials.
    Davey MG; Ryan ÉJ; Donlon NE; Ryan OK; Al Azzawi M; Boland MR; Kerin MJ; Lowery AJ
    Langenbecks Arch Surg; 2023 May; 408(1):180. PubMed ID: 37145303
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Resection margin status at the portomesenteric axis may not determine oncologic outcome after pancreaticoduodenectomy for lymph node-positive pancreatic ductal adenocarcinoma.
    Katou S; Wenning AS; Aeschbacher P; Morgul H; Becker F; Pascher A; Gloor B; Strücker B; Andreou A
    Surgery; 2023 Jul; 174(1):91-99. PubMed ID: 37121858
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. An analysis of time to treatment in patients with pancreatic adenocarcinoma.
    Sugumar K; Gendi S; Quereshy HA; Gupta S; Hue JJ; Rothermel LD; Ocuin LM; Ammori JB; Hardacre JM; Winter JM
    Surgery; 2023 Jul; 174(1):83-90. PubMed ID: 37105784
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 23.